Recombinant adeno‐associated viruses (rAAV) are among the most promising vectors for long‐term gene transduction. These viruses have a high degree of safety, making them ideal for gene therapy applications. Significant progress has been made in improving rAAV vector production and purification. In this webcast, we present a study exploring different chromatography workflow solutions to purify rAAV8. Experimental conditions and data are presented on the use of anion exchange (AEX) and mixed-mode chromatography to purify rAAV8.

Key takeaways:

  • Increased efficiencies using AEX for capture
  • Mixed-mode chromatography used to separate empty capsid from full capsid and remove DNA
  • More flexible, economical purification workflow compared to traditional purification process 

Previous post

StarBright Dyes for Flow Cytometry

Next post

NalaGenetics Moves Pharmacogenomics from the Bench to the Clinic using qPCR: An Interview with Astrid Irwanto, Co-Founder and COO